Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
logoRelationalStocks.com
STOCK TICKER:

Details Of Insider Trading Activities
TransactionCompanyTickerInsiderShares TradedAvg.
Price
Total ValueFiling
2019-02-04
Sale
Editas Medicine, Inc.EDITHack Andrew A. F.
Chief Financial Officer
6,895$21.39$147,484
2019-01-18
Sale
Editas Medicine, Inc.EDITMyer Vickesh
Chief Technology Officer
4,000$26.50$106,000
2019-01-17
Sale
Editas Medicine, Inc.EDITMyer Vickesh
Chief Technology Officer
3,000$26.18$78,540
2019-01-08
Sale
Editas Medicine, Inc.EDITBosley Katrine
President and CEO, Director
12,000$25.27$303,240
2019-01-04
Sale
Editas Medicine, Inc.EDITHack Andrew A. F.
Chief Financial Officer
7,000$22.48$157,360
2018-12-18
Sale
Editas Medicine, Inc.EDITMyer Vickesh
Chief Technology Officer
4,000$27.41$109,640
2018-12-17
Sale
Editas Medicine, Inc.EDITMyer Vickesh
Chief Technology Officer
3,000$27.89$83,670
2018-12-03
Sale
Editas Medicine, Inc.EDITBosley Katrine
President and CEO, Director
12,000$31.92$383,040
2018-11-23
Sale
Editas Medicine, Inc.EDITHack Andrew A. F.
Chief Financial Officer
5,284$28.15$148,744
2018-11-20
Sale
Editas Medicine, Inc.EDITMyer Vickesh
Chief Technology Officer
4,000$26.50$106,000
2018-11-19
Sale
Editas Medicine, Inc.EDITMyer Vickesh
Chief Technology Officer
3,000$28.19$84,570
2018-11-01
Sale
Editas Medicine, Inc.EDITBosley Katrine
President and CEO, Director
12,000$26.88$322,560
2018-10-26
Sale
Editas Medicine, Inc.EDITHack Andrew A. F.
Chief Financial Officer
6,000$25.70$154,200
2018-10-18
Sale
Editas Medicine, Inc.EDITMyer Vickesh
Chief Technology Officer
4,000$29.44$117,760
2018-10-17
Sale
Editas Medicine, Inc.EDITMyer Vickesh
Chief Technology Officer
3,000$28.87$86,610
2018-10-01
Sale
Editas Medicine, Inc.EDITBosley Katrine
President and CEO, Director
12,000$31.02$372,240
2018-09-28
Sale
Editas Medicine, Inc.EDITHack Andrew A. F.
Chief Financial Officer
8,000$32.08$256,640
2018-09-18
Sale
Editas Medicine, Inc.EDITMyer Vickesh
Chief Technology Officer
4,000$32.19$128,759
2018-09-17
Sale
Editas Medicine, Inc.EDITMyer Vickesh
Chief Technology Officer
3,000$32.33$96,990
2018-09-04
Sale
Editas Medicine, Inc.EDITBosley Katrine
President and CEO, Director
12,000$32.35$388,200
2018-08-31
Sale
Editas Medicine, Inc.EDITHack Andrew A. F.
Chief Financial Officer
10,000$32.23$322,299
2018-08-20
Sale
Editas Medicine, Inc.EDITMyer Vickesh
Chief Technology Officer
4,000$29.87$119,480
2018-08-20
Sale
Editas Medicine, Inc.EDITBosley Katrine
President and CEO, Director
12,000$30.17$362,040
2018-08-17
Sale
Editas Medicine, Inc.EDITMyer Vickesh
Chief Technology Officer
3,000$29.65$88,950
2018-08-01
Sale
Editas Medicine, Inc.EDITBosley Katrine
President and CEO, Director
8,333$29.55$246,240
2018-07-18
Sale
Editas Medicine, Inc.EDITMyer Vickesh
Chief Technology Officer
7,000$35.56$248,920
2018-07-17
Sale
Editas Medicine, Inc.EDITMyer Vickesh
Chief Technology Officer
7,000$35.71$249,970
2018-07-02
Sale
Editas Medicine, Inc.EDITBosley Katrine
President and CEO, Director
8,333$36.29$302,404
2018-06-19
Sale
Editas Medicine, Inc.EDITMyer Vickesh
Chief Technology Officer
7,000$38.39$268,730
2018-06-18
Sale
Editas Medicine, Inc.EDITMyer Vickesh
Chief Technology Officer
7,000$38.12$266,840
2018-06-13
Sale
Editas Medicine, Inc.EDITAlbright Charles
Chief Scientific Officer
10,000$35.98$359,799
2018-06-04
Sale
Editas Medicine, Inc.EDITHack Andrew A. F.
Chief Financial Officer
3,000$37.10$111,300
2018-06-01
Sale
Editas Medicine, Inc.EDITBosley Katrine
President and CEO, Director
8,333$37.55$312,904
2018-06-01
Sale
Editas Medicine, Inc.EDITHack Andrew A. F.
Chief Financial Officer
7,000$39.28$274,960
2018-05-23
Sale
Editas Medicine, Inc.EDITAlbright Charles
Chief Scientific Officer
10,000$35.00$350,000
2018-05-18
Purchase
Editas Medicine, Inc.EDITMULLEN JAMES C
Director
10,000$38.03$380,300

1 2 3 Next >

*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*